Cargando…
Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution
The outcome for patients with relapsed Ewing's sarcoma is poor. A retrospective analysis was carried out to identify factors associated with improved survival. Between 1992 and 2002, 114 patients presented with relapsed or progressive disease. Median time to progression/relapse was 13 months (r...
Autores principales: | McTiernan, Anne M., Cassoni, Anna M., Driver, Deirdre, Michelagnoli, Maria P., Kilby, Anne M., Whelan, Jeremy S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698143/ https://www.ncbi.nlm.nih.gov/pubmed/17496997 http://dx.doi.org/10.1155/SRCM/2006/83548 |
Ejemplares similares
-
A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma
por: McTiernan, Anne, et al.
Publicado: (2006) -
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92
por: Whelan, Jeremy, et al.
Publicado: (2018) -
Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis
por: Carter, Thomas J., et al.
Publicado: (2020) -
A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours
por: Meyer, T., et al.
Publicado: (2003) -
Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience
por: Weiss, Kurt R., et al.
Publicado: (2011)